Alonso, M., Val, E., & Rapaport, M. H. (1997). An open-label study of SSRI treatment in depressed hispanic and non-Hispanic women. J Clin Psychiatry, 58(1), 31.

Aydin, M., Hatirnaz, O., Erensoy, N., & Ozbek, U. (2005). CYP2D6 and CYP1A1 mutations in the Turkish population. Cell Biochemistry and Function, 23(2), 133-135.

Bartoli, A., Xiaodong, S., Gatti, G., Cipolla, G., Marchiselli, R., & Perucca, E. (1996). The influence of ethnic factors and gender on CYP1A2-mediated drug disposition: a comparative study in Caucasian and Chinese subjects using phenacetin as a marker substrate. Ther Drug Monit, 18(5), 586-591.

Bigos, K. L., Bies, R. R., Pollock, B. G., Lowy, J. J., Zhang, F., & Weinberger, D. R. (2011). Genetic variation in CYP3A43 explains racial difference in olanzapine clearance. Mol Psychiatry, 16(6), 620-625.

BorisTM - CYP2D6_structure.png, Public Domain, (retrieved march 14th, 2016)

Bousman, C. A., Sarris, J., Won, E. S., Chang, H. S., Singh, A., Lee, H. Y., . . . Ng, C. H. (2014). Escitalopram efficacy in depression: a cross-ethnicity examination of the serotonin transporter promoter polymorphism. J Clin Psychopharmacol, 34(5), 645-648.

Chan, E., Lee, H. S., & Hue, S. S. (2001). Population pharmacokinetics of carbamazepine in Singapore epileptic patients. Br J Clin Pharmacol, 51(6), 567-576.

Chong, K. W., Chan, D. W., Cheung, Y. B., Ching, L. K., Hie, S. L., Thomas, T., . . . Tan, E. C. (2014). Association of carbamazepine-induced severe cutaneous drug reactions and HLA-B*1502 allele status, and dose and treatment duration in paediatric neurology patients in Singapore.

Currier, B. M., Molina, G., & Kato, M. (2004). Citalopram Treatment of Major Depressive Disorder in Hispanic HIV and AIDS Patients: A Prospective Study. Psychosomatics, 45(3), 210-216.

Denic, S., Showqi, S., Klein, C., Takala, M., Nagelkerke, N., & Agarwal, M. M. (2009). Prevalence, phenotype and inheritance of benign neutropenia in Arabs. BMC Blood Disord, 9, 3.

Ferrell, P. B., Jr., & McLeod, H. L. (2008). Carbamazepine, HLA-B*1502 and risk of Stevens-Johnson syndrome and toxic epidermal necrolysis: US FDA recommendations. Pharmacogenomics, 9(10), 1543-1546.

Fricke-Galindo, I., Cespedes-Garro, C., Rodrigues-Soares, F., Naranjo, M. E., Delgado, A., de Andres, F., . . . A, L. L. (2015). Interethnic variation of CYP2C19 alleles, 'predicted' phenotypes and 'measured' metabolic phenotypes across world populations. Pharmacogenomics J.

Fu, Y., Fan, C. H., Deng, H. H., Hu, S. H., Lv, D. P., Li, L. H., . . . Lu, X. Q. (2006). Association of CYP2D6 and CYP1A2 gene polymorphism with tardive dyskinesia in Chinese schizophrenic patients. Acta Pharmacol Sin, 27(3), 328-332.

Ghoneim, M. M., Korttila, K., Chiang, C. K., Jacobs, L., Schoenwald, R. D., Mewaldt, S. P., & Kayaba, K. O. (1981). Diazepam effects and kinetics in Caucasians and Orientals. Clin Pharmacol Ther, 29(6), 749-756.

González-Galarza, Faviel F., Takeshita, Louise Y. C., Santos, Eduardo J. M., Kempson, F., Maia, Maria Helena T., Silva, Andrea Luciana Soares d., . . . Middleton, D. (2015). Allele frequency net 2015 update: new features for HLA epitopes, KIR and disease and HLA adverse drug reaction associations. Nucleic Acids Research, 43(D1), D784-D788.

Haddy, T. B., Rana, S. R., & Castro, O. (1999). Benign ethnic neutropenia: what is a normal absolute neutrophil count? J Lab Clin Med, 133(1), 15-22.

Hashemi, J., Kheirabadi, G., & Movahedian, A. (2006). Lithium ratio in bipolar patients in Isfahan, Iran. 2006, 11(4), 257-262.

Ingelman-Sundberg M. Genetic polymorphisms of cytochrome. P450 2D6 (CYP2D6): Clinical consequences, evolutionary aspects and functional diversity. Pharmacogenomics J 2005;5:6-13.

Jann, M. W., Chang, W. H., Lam, Y. W., Hwu, H. G., Lin, H. N., Chen, H., . . . et al. (1992). Comparison of haloperidol and reduced haloperidol plasma levels in four different ethnic populations. Prog Neuropsychopharmacol Biol Psychiatry, 16(2), 193-202

Kaniwa, N., Saito, Y., Aihara, M., Matsunaga, K., Tohkin, M., Kurose, K., . . . for the, J. r. g. (2010). HLA-B*1511 is a risk factor for carbamazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in Japanese patients. Epilepsia, 51(12), 2461-2465.

Kishimoto, A., & Hollister, L. E. (1984). Nortriptyline kinetics in Japanese and Americans. J Clin Psychopharmacol, 4(3), 171-172.

Kuzmanovska, M., Dimishkovska, M., Maleva Kostovska, I., Noveski, P., Sukarova Stefanovska, E., & Plaseska-Karanfilska, D. (2015). CYP2D6 allele distribution in Macedonians, Albanians and Romanies in the Republic of Macedonia. Balkan Journal of Medical Genetics : BJMG, 18(2), 49-58.

Lazalde-Ramos, B. P., Martinez-Fierro Mde, L., Galaviz-Hernandez, C., Garza-Veloz, I., Naranjo, M. E., Sosa-Macias, M., & Llerena, A. (2014). CYP2D6 gene polymorphisms and predicted phenotypes in eight indigenous groups from northwestern Mexico. Pharmacogenomics, 15(3), 339-348.

Leckband, S., Kelsoe, J., Dunnenberger, H., Jr, A. G., Tran, E., Berger, R., . . . Pirmohamed, M. (2013). Clinical Pharmacogenetics Implementation Consortium Guidelines for HLA-BGenotype and Carbamazepine Dosing. reactions, 1, 11.

Lesser, I. M., Castro, D. B., Gaynes, B. N., Gonzalez, J., Rush, A. J., Alpert, J. E., . . . Wisniewski, S. R. (2007). Ethnicity/race and outcome in the treatment of depression: results from STAR*D. Med Care, 45(11), 1043-1051.

Lin, K. M., Poland, R. E., Lau, J. K., & Rubin, R. T. (1988). Haloperidol and prolactin concentrations in Asians and Caucasians. J Clin Psychopharmacol, 8(3), 195-201.

Llerena, A., Naranjo, M. E. G., Rodrigues-Soares, F., Penas-Lledó, E. M., Fariñas, H., & Tarazona-Santos, E. (2014). Interethnic variability of CYP2D6 alleles and of predicted and measured metabolic phenotypes across world populations. Expert Opinion on Drug Metabolism & Toxicology, 10(11), 1569-1583.

Locharernkul, C., Loplumlert, J., Limotai, C., Korkij, W., Desudchit, T., Tongkobpetch, S., . . . Shotelersuk, V. (2008). Carbamazepine and phenytoin induced Stevens-Johnson syndrome is associated with HLA-B*1502 allele in Thai population. Epilepsia, 49(12), 2087-2091.

Ng, C. H., Chong, S. A., Lambert, T., Fan, A., Hackett, L. P., Mahendran, R., . . . Schweitzer, I. (2005). An inter-ethnic comparison study of clozapine dosage, clinical response and plasma levels. Int Clin Psychopharmacol, 20(3), 163-168.

Obach, R. S., Cox, L. M., & Tremaine, L. M. (2005). Sertraline is metabolized by multiple cytochrome P450 enzymes, monoamine oxidases, and glucuronyl transferases in human: an in vitro study.

Tangamornsuksan, W., Chaiyakunapruk, N., Somkrua, R., Lohitnavy, M., & Tassaneeyakul, W. (2013). Relationship between the hla-b*1502 allele and carbamazepine-induced stevens-johnson syndrome and toxic epidermal necrolysis: A systematic review and meta-analysis. JAMA Dermatology, 149(9), 1025-1032.

Rajagopal, S. (2005). Clozapine, agranulocytosis, and benign ethnic neutropenia. Postgrad Med J, 81(959), 545-546.

Roman, T., Szobot, C., Martins, S., Biederman, J., Rohde, L. A., & Hutz, M. H. (2002). Dopamine transporter gene and response to methylphenidate in attention-deficit/hyperactivity disorder. Pharmacogenetics, 12(6), 497-499.

Rudorfer, M. V., Lane, E. A., Chang, W. H., Zhang, M. D., & Potter, W. Z. (1984). Desipramine pharmacokinetics in Chinese and Caucasian volunteers. Br J Clin Pharmacol, 17(4), 433-440.

Sanchez-Lacay, J. A., Lewis-Fernandez, R., Goetz, D., Blanco, C., Salman, E., Davies, S., & Liebowitz, M. (2001). Open trial of nefazodone among Hispanics with major depression: efficacy, tolerability, and adherence issues. Depress Anxiety, 13(3), 118-124.

Shimoda, K., Jerling, M., Bottiger, Y., Yasuda, S., Morita, S., & Bertilsson, L. (1999). Pronounced differences in the dispositon of clomipramine between Japanese and Swedish patients. J Clin Psychopharmacol, 19(5), 393-400.

Shoenfeld, Y., Alkan, M. L., Asaly, A., Carmeli, Y., & Katz, M. (1988). Benign familial leukopenia and neutropenia in different ethnic groups. Eur J Haematol, 41(3), 273-277.

Strickland, T. L., K. M. Lin, P. Fu, D. Anderson and Y. Zheng (1995). "Comparison of lithium ratio between African-American and Caucasian bipolar patients." Biol Psychiatry 37(5): 325-330.

Tamminga, W. J., Wemer, J., Oosterhuis, B., Weiling, J., Wilffert, B., de Leij, L. F., . . . Jonkman, J. H. (1999). CYP2D6 and CYP2C19 activity in a large population of Dutch healthy volunteers: indications for oral contraceptive-related gender differences. Eur J Clin Pharmacol, 55(3), 177-184.

Tangamornsuksan, W., Chaiyakunapruk, N., Somkrua, R., Lohitnavy, M., & Tassaneeyakul, W. (2013). Relationship between the hla-b*1502 allele and carbamazepine-induced stevens-johnson syndrome and toxic epidermal necrolysis: A systematic review and meta-analysis. JAMA Dermatology, 149(9), 1025-1032.

Varshney, E., Saha, N., Tandon, M., Shrivastava, V., & Ali, S. (2012). Prevalence of poor and rapid metabolizers of drugs metabolized by CYP2B6 in North Indian population residing in Indian national capital territory. Springerplus, 1, 34.

Verma, S. K., Tan, C. H., Chan, Y. H., & Chong, S. A. (2005). Plasma risperidone levels and clinical response in patients with first-episode psychosis. J Clin Psychopharmacol, 25(6), 609-611.

Yu, Y. W., Tsai, S. J., Chen, T. J., Lin, C. H., & Hong, C. J. (2002). Association study of the serotonin transporter promoter polymorphism and symptomatology and antidepressant response in major depressive disorders. Mol Psychiatry, 7(10), 1115-1119.

Zeng, T., Long, Y. S., Min, F. L., Liao, W. P., & Shi, Y. W. (2015). Association of HLA-B*1502 allele with lamotrigine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in Han Chinese subjects: a meta-analysis. Int J Dermatol, 54(4), 488-493.